Rockville, Md., December 4, 2008 In a decision to focus full attention and resources on its core standards-setting activities, USP will transfer its reporting programs, MEDMARX and the Medication Errors Reporting (MER) Program, to Quantros and the Institute for Safe Medication Practices (ISMP), respectively. This decision in no way signals a shift by USP away from its important patient safety efforts. Rather, USP will use data from these and other programs to enhance its standards-setting activities to promote patient safety and safe medication use. USP will take advantage of the growing number of new Patient Safety Organizations (PSO) to inform the product and practice standards established by its standards-setting body, the Council of Experts. The PSO is a designation created by the Federal Patient Safety and Quality Improvement Act of 2005 to encourage clinicians and healthcare organizations to identify, analyze, and reduce the risks and hazards associated with patient care, including errors associated with the administration and use of medications.
USP's leadership in medication error reporting and prevention has been an important part of its public health activities for several decades, with major contributions based on the work of distinguished volunteers in USP's Council of Experts using data and information from MEDMARX and the MER Program. "USP has been an incubator for groundbreaking pilot programs in the arena of medication error data collection, analysis and reporting," stated Roger L. Williams, M.D., USP's executive vice president and CEO. "These programs have reached the level of development where there is greater benefit to public health for USP to transfer core activities of these programs to our strategic partners, who will bring the programs to the next level of effectiveness and impact." USP will maintain access to the data from the two programs so it can be used in standards-setting activities of the Council of Experts and, particularly, in those Expert Committees that speak directly to practitioner interests. These and allied standards-setting activities are outlined in the USP Board of Trustees' new strategic plan (www.usp.org/aboutUSP/whereWereGoing.html).
USP began collecting medication error data through its own programs in 1991, but has been involved in analyzing such data for more than 30 years. USP found early on that information gleaned from error records added a medication safety component to its product standards and later led the way for its work in practice standards. USP also played an important role in the drafting and enactment of legislative changes such as the Patient Safety and Quality Improvement Act of 2005. USP continues its 188-year commitment to medication safety through its core mission of standards setting.
The following provides further information about USP reporting programs, medication safety standards setting and continued patient safety activities.
|Contact: Laura Provan|